-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BjvQqSq3PbIyjbUfsOJo6YEdBmTxPxrTHZJjHIdBagivUe+EyBVJy926JB1qiLEb v03eCxG2CeO7rfti8qsknA== 0001238921-07-000018.txt : 20070620 0001238921-07-000018.hdr.sgml : 20070620 20070620123615 ACCESSION NUMBER: 0001238921-07-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070619 FILED AS OF DATE: 20070620 DATE AS OF CHANGE: 20070620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIBBERD CHRISTOPHER R CENTRAL INDEX KEY: 0001238921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 07930680 BUSINESS ADDRESS: STREET 1: C/O BIOSITE INC STREET 2: 11030 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584554808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-06-19 0 0000834306 BIOSITE INC BSTE 0001238921 HIBBERD CHRISTOPHER R BIOSITE INCORPORATED 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 1 Senior Vice President Corpo Senior Vice President Corpo Common Stock 2007-06-19 4 M 0 1 44.18 A 32106 D Common Stock 9075 I by Trust Non-Qualified Stock Option (right to buy) 44.18 2007-06-19 4 M 0 1 0 D 2004-06-18 2014-06-18 Common Stock 1 2280 D Option vests daily over a four-year period commencing on the date of grant, except that no options are exercisable for the first six months after the date of grant. By: Robyn Shutak For: Chris R. Hibberd 2007-06-20 -----END PRIVACY-ENHANCED MESSAGE-----